4
Changes in Ownership
Inhibikase Therapeutics, Inc. Filed Acc 0000950170-23-031850
Options or other derivatives
- Director acquired 6,667 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Freeman Roy Lester Director | 2023-06-30 | Grant or award · Stock Option (right to buy) | +6,667 | 6,667 | D | ||
Loading xslF345X04/ownership.xml…